此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Robot and tDCS Based Proprioceptive Rehabilitation After Stroke (RoboStim)

2019年3月20日 更新者:Dr. Sean Dukelow、University of Calgary

The Combined Effect of Robotic Rehabilitation and Transcranial Direct Current Stimulation on Proprioception in Chronic Stroke: a Pilot Study

Proprioceptive deficits are common following stroke, yet current evidence-based approaches for rehabilitating proprioception are limited. Robotic rehabilitation and transcranial direct current stimulation (tDCS) are two promising technologies/techniques that can potentially be used to treat these deficits. This study's purpose is to determine whether robotic rehabilitation, specifically targeted at proprioception, has the capacity to improve proprioception in a chronic stroke population. Furthermore, it is interested in whether tDCS is able to enhance any potential improvements in proprioception as a result of robotic rehabilitation.

It is hypothesized that a robotic rehabilitation will enhance proprioception in a chronic stroke population beyond standard of care rehabilitation. It is also hypothesized that individuals receiving a combination of robotic rehabilitation and tDCS will show greater proprioceptive improvements than those just receiving robotic rehabilitation.

研究概览

详细说明

Background and Rationale: Proprioception is the awareness of where our limbs are in space, in the absence of vision. It is an important sense that allows us to have control over our movement and perform many activities of daily living. Every year, approximately 62,000 Canadians suffer from a stroke. Around 50% of individuals who suffer from a stroke are left with deficits in proprioception, yet clinically very little is done to rehabilitate this sense. Two novel interventions for rehabilitating proprioception are robotic rehabilitation and Transcranial Direct Current Stimulation (tDCS). Robotic rehabilitation is potentially beneficial over conventional therapies as the number of repetitions performed in a single session can be drastically increased and these movements can be performed in a well-controlled manner, something that is more difficult in conventional therapy. It is also easy to occlude vision when performing rehabilitation in a robotic environment, meaning proprioceptive retraining can be explicitly targeted. tDCS is another technology which has the potential to enhance rehabilitation. The technique involves placing two sponge electrodes over the scalp and passing a small electrical current (1-2mA) between the two electrodes, altering the membrane potential of the brain tissue through which the current passes. When tDCS has been paired with training, it has been shown to enhance learning in both healthy and stroke populations. tDCS has yet to be investigated to improve proprioception in a stroke population.

Research Question: Can a combination of robotic rehabilitation and tDCS enhance proprioception in a chronic stroke population?

Ethics: This study has been approved by the Research Ethics Board at the University of Calgary

Design: This is a Single-Blinded, Pilot, Randomized Controlled Trial with a Sham Arm

----------Methods----------

Recruitment: 30 individuals with proprioceptive deficits beyond 6-months post-stroke are being recruited from the outpatient stroke community in Calgary, Alberta, Canada.

Randomization: Individuals are randomized into one of three groups: robotic rehabilitation plus anodal tDCS, robotic rehabilitation plus sham tDCS or standard of care rehabilitation.

Robotic Intervention: The robotic rehabilitation intervention consists of 10-days of robotic therapy in the Kinesiological Instrument for Normal and Altered Reaching Movements (KINARM) Exoskeleton. Robotic rehabilitation is conducted for 1 hour each day, on 10 consecutive days (excluding weekends). Therapy is tailored specifically towards rehabilitating proprioception and consists of a battery of 5 simple video game-like tasks. Each task is performed for 10-15 minutes each day. The order in which these tasks are completed are pseudo-randomized each day. Each day a motivation questionnaire will be completed.

tDCS Intervention: In addition to robotic rehabilitation, those in the tDCS group will also receive 20 minutes of 2mA anodal tDCS. This is applied during the first 20 minutes of each robotic session and is targeted over the ipsilesional sensory cortex. For the sham condition, the same setup will be used. Each day a tDCS tolerability questionnaire will be completed.

Assessments: All subjects will undergo 3 robotic assessments of proprioceptive performance, one at baseline (day 1), one immediately after the intervention (day 12) and one more at 3 months follow up. Two components of proprioception will be assessed during these robotic assessments (position sense and movement sense). Robotic assessments will be conducted in the same robotic exoskeleton that the therapy is delivered in.

A variety of clinical scales (Fugl-Meyer Assessment, Functional Independence Measure, and Nottingham Sensory Scale) will be collected at each time point. These will be secondary outcome measures. Performance on a robotic assessment of visually-guided reaching will also be a secondary outcome measure. All clinical assessments will be performed by a blinded assessor therapist.

Data analysis: Primary outcome measures will be analysed using a repeated measures ANOVA. Comparisons will be made between groups at each assessment time points. Secondary outcome measures and questionnaire data will also be analysed with a repeated measures ANOVA.

研究类型

介入性

注册 (预期的)

30

阶段

  • 阶段2

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

学习地点

    • Alberta
      • Calgary、Alberta、加拿大、T2N 2T9
        • 招聘中
        • Stroke Robotic and Recovery Lab, Foothills Medical Centre
        • 接触:
        • 接触:
        • 首席研究员:
          • Sean P Dukelow, MD/PHD

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 99年 (成人、年长者)

接受健康志愿者

有资格学习的性别

全部

描述

Inclusion Criteria:

  1. Sex - Both male and female
  2. Age: 18 years and older
  3. Stroke onset: >6 months prior to enrolment
  4. Stroke type: Hemorrhagic and ischaemic
  5. Evidence of proprioceptive deficits as determined by a robotic assessment
  6. Ability to follow simple 3-step commands

Exclusion Criteria:

  1. Other co-morbid neurologic diagnoses (eg. Parkinson's disease)
  2. Seizure disorder
  3. Enrolment in concurrent upper extremity intervention trial
  4. Metal implants in head
  5. significant upper extremity orthopedic issues

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:双倍的

武器和干预

参与者组/臂
干预/治疗
实验性的:Robotic Rehabilitation plus 1x1 anodal tDCS
Receive 10 days of 1hr robotic rehabilitation with the KINARM Exoskeleton, in addition to 20 minutes, 2mA anodal tDCS (Soterix 1x1 tDCS) over the ipsilesional sensory cortex during the first 20 minutes of each robotic session. Current is ramped up to 2mA over 30 seconds and ramped back down over 30 seconds at the end of the 20 minutes.
20 minutes of 2mA anodal tDCS applied by a Soterix Medical 1x1 tDCS device while the participants are doing the robotic rehabilitation
其他名称:
  • Direct current stimulator (Soterix Medical)
10 days of robotic rehabilitation targeted at proprioception. Therapy is conducted for 1 hour each day for 10 consecutive days (excluding weekends), in combination with either anodal or sham tDCS.
其他名称:
  • KINARM Exoskeleton (BKIN Technologies)
假比较器:Robotic Rehabilitation plus sham tDCS
Receive 10 days of 1hr robotic rehabilitation with the KINARM Exoskeleton, in addition to sham anodal tDCS over the ipsilesional sensory cortex. Current is ramped up to 2mA over 30 seconds and immediately ramped back down over 30 seconds. This is repeated after 20 minutes.
10 days of robotic rehabilitation targeted at proprioception. Therapy is conducted for 1 hour each day for 10 consecutive days (excluding weekends), in combination with either anodal or sham tDCS.
其他名称:
  • KINARM Exoskeleton (BKIN Technologies)
Sham 2mA anodal tDCS applied by a Soterix Medical 1x1 tDCS device while the participants are doing the robotic rehabilitation
其他名称:
  • Direct current stimulator (Soterix Medical)
无干预:Standard of Care Rehabilitation
No additional therapy/treatment provided. The individual continues with their normal daily routine

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Robotic limb position matching standardized score
大体时间:Baseline, Within 1 week of completing the 10 day intervention and 3-month follow-up
Change in a standardized score from a baseline robotic assessment of limb position matching
Baseline, Within 1 week of completing the 10 day intervention and 3-month follow-up
Robotic kinaesthesia standardized score
大体时间:Baseline, Within 1 week of completing the 10 day intervention and 3-month follow-up
Change in a standardized score from a baseline robotic assessment of kinaesthesia (movement sense)
Baseline, Within 1 week of completing the 10 day intervention and 3-month follow-up

次要结果测量

结果测量
措施说明
大体时间
Change in Upper-Extremity Fugl-Meyer Assessment scores
大体时间:Baseline, Within 1 week of completing the 10 day intervention and 3-month follow-up
Difference in subscale scores on the Upper-Extremity Fugl-Meyer Assessment - both Motor (max 66) and Sensory (max 12) components. Higher scores indicate better outcome.
Baseline, Within 1 week of completing the 10 day intervention and 3-month follow-up
Change in Nottingham Sensory Assessment scores
大体时间:Baseline, Within 1 week of completing the 10 day intervention and 3-month follow-up
Difference in subscale scores on the Nottingham Sensory Assessment - upper extremity only (Light touch, temperature, pinprick, pressure, tactile localization, bilateral simultaneous touch, proprioception - max score 12 for each subscale)
Baseline, Within 1 week of completing the 10 day intervention and 3-month follow-up
Change in Functional Independence Measure score
大体时间:Baseline, Within 1 week of completing the 10 day intervention and 3-month follow-up
Difference in score on the Functional Independence Measure (Higher scores indicate better outcome, max score 126)
Baseline, Within 1 week of completing the 10 day intervention and 3-month follow-up

其他结果措施

结果测量
措施说明
大体时间
tDCS Tolerability
大体时间:During 10 day intervention period
The questionnaire will be completed after every session
During 10 day intervention period
Attention/Motivation Questionnaire
大体时间:During the 10 day intervention period
The questionnaire will be completed before and after every session. Higher scores indicate greater motivation, max score = 90
During the 10 day intervention period

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2018年3月6日

初级完成 (预期的)

2020年8月31日

研究完成 (预期的)

2020年8月31日

研究注册日期

首次提交

2019年3月18日

首先提交符合 QC 标准的

2019年3月20日

首次发布 (实际的)

2019年3月25日

研究记录更新

最后更新发布 (实际的)

2019年3月25日

上次提交的符合 QC 标准的更新

2019年3月20日

最后验证

2019年3月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

IPD 计划说明

No plan to make IPD available to other researchers

药物和器械信息、研究文件

研究美国 FDA 监管的药品

研究美国 FDA 监管的设备产品

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

1x1 anodal tDCS的临床试验

3
订阅